scholarly journals Canadian Guidelines on Cannabis Use Disorder Among Older Adults

2020 ◽  
Vol 23 (1) ◽  
pp. 135-142
Author(s):  
Jonathan R. Bertram ◽  
Amy Porath ◽  
Dallas Seitz ◽  
Harold Kalant ◽  
Ashok Krishnamoorthy ◽  
...  
Keyword(s):  
Mental Health ◽  
Older Adults ◽  
Substance Use ◽  
Financial Support ◽  
Cannabis Use ◽  
Cannabis Use Disorder ◽  
Full Version ◽  
Assessment And Treatment ◽  
Health Canada

BackgroundCannabis Use Disorder (CUD) is an emerging and diverse challenge among older adults.MethodsThe Canadian Coalition for Seniors’ Mental Health, with financial support from Health Canada, has produced evidencebased guidelines on the prevention, identification, assessment, and treatment of this form of substance use disorder.ConclusionsOlder adults may develop CUD in the setting of recreational and even medical use. Clinicians should remain vigilant for the detection of CUD, and they should be aware of strategies for prevention and managing its emergence and consequences The full version of these guidelines can be accessed at www.ccsmh.ca.

Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review

2021 ◽  
pp. 1-12
Author(s):  
Rachel Lees ◽  
Lindsey A. Hines ◽  
Deepak Cyril D'Souza ◽  
George Stothart ◽  
Marta Di Forti ◽  
...  
Keyword(s):  
Mental Health ◽  
Clinical Decision Making ◽  
Treatment Compliance ◽  
Narrative Review ◽  
Cannabis Use ◽  
Psychotic Symptoms ◽  
Motivational Enhancement Therapy ◽  
Cannabis Use Disorder ◽  
Pharmacological Treatments ◽  
Health Comorbidities

Abstract Cannabis is the most widely used illicit drug worldwide, and it is estimated that up to 30% of people who use cannabis will develop a cannabis use disorder (CUD). Demand for treatment of CUD is increasing in almost every region of the world and cannabis use is highly comorbid with mental disorders, where sustained use can reduce treatment compliance and increase risk of relapse. In this narrative review, we outline evidence for psychosocial and pharmacological treatment strategies for CUD, both alone and when comorbid with psychosis, anxiety or depression. Psychosocial treatments such as cognitive behavioural therapy, motivational enhancement therapy and contingency management are currently the most effective strategy for treating CUD but are of limited benefit when comorbid with psychosis. Pharmacological treatments targeting the endocannabinoid system have the potential to reduce cannabis withdrawal and cannabis use in CUD. Mental health comorbidities including anxiety, depression and psychosis hinder effective treatment and should be addressed in treatment provision and clinical decision making to reduce the global burden of CUDs. Antipsychotic medication may decrease cannabis use and cannabis craving as well as psychotic symptoms in patients with CUD and psychosis. Targeted treatments for anxiety and depression when comorbid with CUD are feasible.

Legal substance use and the development of a DSM-IV cannabis use disorder during adolescence: the TRAILS study

Addiction ◽  
2013 ◽  
Vol 109 (2) ◽  
pp. 303-311 ◽  
Author(s):  
Andrea Prince van Leeuwen ◽  
Hanneke E. Creemers ◽  
Frank C. Verhulst ◽  
Wilma A. M. Vollebergh ◽  
Johan Ormel ◽  
...  
Keyword(s):  
Substance Use ◽  
Cannabis Use ◽  
Cannabis Use Disorder ◽  
Dsm Iv

Psychological Assessment and Treatment of Older Adults

2021 ◽  
Keyword(s):  
Mental Health ◽  
Older Adults ◽  
Mental Health Professionals ◽  
Psychological Assessment ◽  
Health Professionals ◽  
Assessment Tool ◽  
Skill Assessment ◽  
Case Examples ◽  
Assessment And Treatment ◽  
Comprehensive Text

Mental health practitioners are encountering an ever-growing number of older adults and so an up-to-date and comprehensive text addressing the special considerations that arise in the psychological assessment and treatment of this population is vital. This accessible handbook does just that by introducing the key topics that psychologists and other health professionals face when working with older adults. Each area is introduced and then the special considerations for older adults are explored, including specific ethical and healthcare system issues. The use of case examples brings the topics further to life. An important feature of the book is the interweaving of diversity issues (culture, race, sexuality, etc.) within the text to lend an inclusive, contemporary insight into these important practice components. The Pikes Peak Geropsychology Knowledge and Skill Assessment Tool is included in an appendix so readers can test their knowledge, which will be helpful for those aiming for board certification in geropsychology (ABGERO). This an ideal text for mental health professionals transitioning to work with older clients, for those wanting to improve their knowledge for their regular practice, and for trainees or young clinicians just starting out.

Longitudinal course of mental health symptoms among veterans with and without cannabis use disorder.

2021 ◽  
Author(s):  
Nicholas A. Livingston ◽  
Stacey L. Farmer ◽  
Colin T. Mahoney ◽  
Brian P. Marx ◽  
Terence M. Keane
Keyword(s):  
Mental Health ◽  
Cannabis Use ◽  
Cannabis Use Disorder ◽  
Mental Health Symptoms ◽  
Health Symptoms ◽  
Longitudinal Course

Intoxication and drugs in facilities

2015 ◽  
Author(s):  
Jason D. Ourada ◽  
Kenneth L. Appelbaum
Keyword(s):  
Mental Health ◽  
Substance Use ◽  
Active Substance ◽  
Mental Health Problems ◽  
Interdisciplinary Approach ◽  
Clinical Intervention ◽  
Comprehensive Treatment ◽  
Therapeutic Alliances ◽  
Assessment And Treatment ◽  
Life Threatening

Active abuse of substances by inmates poses a challenge for correctional psychiatrists. Substance use disorders (SUD) are common among inmates, with higher prevalence usually found in those with general psychiatric conditions. Knowledge about substance use in correctional facilities fosters competent clinical intervention and enhances management at all levels. Psychiatrists working in jails and prisons have the challenging task of maintaining therapeutic alliances with patients who have co-occurring SUDs and also may be actively using substances. Patients might not spontaneously report use during incarceration because they fear retribution by correctional staff or not receiving needed treatment for medical and mental health problems. Psychiatrists need to remain aware of this and to screen for SUD and active substance use as part of comprehensive treatment planning. The clinical challenges in jails and prisons differ, and the substances found in facilities vary geographically. Active substance abuse by inmates presents clinical and systemic challenges for correctional psychiatrists. The interplay among mental health, medical, and custody staff regarding screening, detection, triage, management, and treatment lies at the heart of these challenges. Correctional psychiatrists make important contributions by providing direct assessment and treatment to inmates, and by offering educational, clinical, and policy consultations to other staff. These contributions help prevent potentially life-threatening complications of intoxication and withdrawal, ensure integrated and evidence-based care, and avoid misguided or ill-informed disciplinary or other institutional practices. This chapter highlights these differences, outlines clinical management, and describes an interdisciplinary approach to intervention.

Participation in 12-Step Programs and Drug Use Among Older Adults With Cannabis Use Disorder: Six-Month Outcomes

2020 ◽  
Vol 51 (1) ◽  
pp. 38-49
Author(s):  
Erin L. Woodhead ◽  
Deborah Brief ◽  
Maureen Below ◽  
Christine Timko
Keyword(s):  
Older Adults ◽  
Drug Use ◽  
Cannabis Use ◽  
Twelve Step ◽  
Cannabis Use Disorder ◽  
Program Participation ◽  
Twelve Step Program ◽  
Step Program ◽  
Time Point

This study examined associations among cannabis use disorder (CUD), 12-step program participation, and cannabis and other drug use at baseline and 3- and 6-month follow-ups. Participants were age 50 or older in a study of veterans receiving medical management of alcohol and/or opioid withdrawal ( N = 171). Generalized estimating equations examined the extent to which time point, 12-step program participation, and CUD were associated with change in number of cannabis and non-cannabis drug use days. Also examined was whether having CUD was associated with 12-step program participation. From baseline through the 6-month follow-up, 12-step program participation increased, non-cannabis drug use decreased, and cannabis use remained stable. Twelve-step program participation at baseline was associated with better outcomes at follow-ups. Participants with CUD reported less 12-step program participation and more cannabis use days at follow-ups. Older adults with CUD may need other types of psychosocial treatments due to low participation in 12-step programs.

Sign in / Sign up

Export Citation Format

Share Document